MedyMatch, IBM Watson Health to use cognitive imaging tech to identify head trauma and stroke

MedyMatch - IBM Watson Health

MedyMatch Technology has teamed-up with IBM Watson Health to bring MedyMatch’s Artificial Intelligence-based clinical decision support application to imaging experts working in acute care settings to help doctors identify instances of intracranial bleeding as a result of head trauma and stroke. Initially, IBM Watson Health’s Imaging group will distribute the MedyMatch brain bleed detection application globally through its vendor neutral sales channels. Then, the two parties will develop interoperability between MedyMatch’s application and IBM Watson Health Imaging’s offerings.

MedyMatch aims to use cognitive tools to help physicians assess patients suspected of head trauma or stroke, and rule out the presence of a bleed in the brain. The MedyMatch algorithm relies on sophisticated deep learning, machine vision, patient data, and clinical insights to automatically highlight for a physician regions of interest that could indicate the potential presence of cerebral bleeds.

“Engaging closely with IBM allows for a near-zero footprint implementation at a customer location delivering ‘A.I. to the bedside’ where I believe the future of healthcare lies,” Gene Saragnese, chairman & CEO of MedyMatch, said in a statement. “At MedyMatch, we believe improvements in the interpretation of data will lead to better decisions, better decisions will lead to better outcomes for patients and lower cost for healthcare. This is what drives us forward every day.”

MedyMatch - IBM Watson Health - image

MedyMatch is currently conducting a clinical trial for its intracranial bleed assessment application and is working towards a PMA Class III approval by the U.S. FDA.

According to the American Heart Association and American Stroke Association, stroke is the fourth leading cause of death and one of the top causes of preventable disability in the United States. Affecting 4% of the U.S. adults, it is forecasted that by 2030, there will be approximately 3.4 million stroke victims annually in the U.S., costing the healthcare system $240 Billion on an annual basis.